Crystal structure of antibiotics bound to the 30S ribosome and its use
View Patent ↗The invention provides high resolution X-ray crystal structures of the 30S ribosome, obtained from Thermus thermophilus 30S subunit, having a tetragonal space group P4 1 2 1 2 to which are bound an antibiotic selected from the group paromomycin, streptomycin, spectinomycin, tetracycline, pactamycin and hygromycin B. An advantageous feature of the structure is that it diffracts at about 3 Å resolution. The invention also provides a crystal of 30S having the three dimensional atomic coordinates of the 30S ribosome, the coordinates being provided in any one of tables 1 to 4. The data may be used for the rational design and modelling of inhibitors for the 30S ribosome, which have potential use as antibiotics.
1. A method of identifying a binding partner of the 30S ribosomal subunit comprising the steps of:
(a) characterizing (i) an active site of the 30S ribosomal subunit from Thermus thermophilus from the atomic coordinates found in Table 1A, Table 1B, Table 1C, Table 2, Table 3, or Table 4 or (ii) an active site of a 30S ribosomal subunit by comparison to the atomic coordinates found in Table 1A, Table 1B, Table 1C, Table 2, Table 3, or Table 4, wherein said active site (i) or (ii) is bound by an antibiotic selected from the group consisting of paromomycin, streptomycin, spectinomycin, tetracycline, pactamycin, and hygromycin B and wherein the atomic coordinates of the selected antibiotic appear in the utilized table;
(b) designing or selecting a binding partner that interacts with said active site (i) or (ii) in the absence of said selected antibiotic; and
(c) obtaining or synthesizing said binding partner.
2. The method of claim 1 , wherein said active site is characterized from the three-dimensional structure of the 30S subunit from the atomic coordinates.
3. The method of claim 1 , wherein said active site is characterized from the three-dimensional structure of at least one sub-domain of the 30S subunit from the atomic coordinates.
4. The method of claim 1 , wherein said binding partner is an inhibitor of a 30S subunit.
5. The method of claim 1 wherein said active site of step (a)(ii) is characterized by homology modeling using the atomic coordinate data.
6. The method of claim 1 wherein said active site is characterized by molecular replacement using the atomic coordinate data.
7. The method of claim 1 wherein said antibiotic is paromomycin.
8. The method of claim 1 wherein said antibiotic is streptomycin.
9. The method of claim 1 wherein said antibiotic is spectinomycin.
10. The method of claim 1 wherein said antibiotic is tetracycline.
11. The method of claim 1 wherein said antibiotic is pactamycin.
12. The method of claim 1 wherein said antibiotic is hygromycin B.